Russian ambassador urges NATO to abandon military domination policyRussian Politics & Diplomacy March 30, 21:05
Three Russian cities interested in hosting 2023 Basketball World ChampionshipSport March 30, 21:02
White House gives no specific dates for Russian-US summitWorld March 30, 20:23
United Arab Emirates shows interest in Russian helicoptersBusiness & Economy March 30, 20:19
NATO secretary general says ceasefire in Donbass works only on paperWorld March 30, 19:47
Putin not against Russian businessman Deripaska speaking to US Congress about ManafortRussian Politics & Diplomacy March 30, 18:55
Russian space rocket center receives first tested engines for Soyuz spacecraftScience & Space March 30, 18:42
Ukrainian president orders to implement ceasefire starting from April 1World March 30, 18:41
Google agrees with basic terms of amicable agreement with Russian anti-trust regulatorBusiness & Economy March 30, 18:18
MOSCOW, June 19. /ITAR-TASS/. Russian pharmaceutical producer R-Pharm will invest €30 million in constructing a biotechnological plant in Turkey, CEO Vasily Ignatyev said late on Wednesday.
In 2013, R-Pharm established a joint venture with a Turkish partner aimed at selling R-Pharm’s medicines in Turkey, the Middle East and the northern Africa.
“We hope to get all necessary documents for clearance until the end of the year and to start the earthworks. We plan to finish the construction and to set up equipment until the end of 2016. The commercial launch will be made, as we expect, in late 2017,” Ignatyev said.
R-Pharm will invest €100 million in its Turkish business until 2018, he said.
Ignatyev separately said that the company will close the deal to purchase a plant from a large pharmaceutical company in Germany until the end of 2014.